Intrauterine smoke exposure deregulates lung function, pulmonary transcriptomes, and in particular insulin-like growth factor (IGF)-1 in a sex-specific manner by Dehmel, Stefan et al.
1SCIENTIFIC REPORtS |  (2018) 8:7547  | DOI:10.1038/s41598-018-25762-5
www.nature.com/scientificreports
Intrauterine smoke exposure 
deregulates lung function, 
pulmonary transcriptomes, and in 
particular insulin-like growth factor 
(IGF)-1 in a sex-specific manner
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Katrin Milger1,4, Gerrit John-Schuster1, Ali Oender Yildirim1, Machteld Hylkema  5,  
Martin Irmler6, Johannes Beckers6,7,8, Bianca Schaub1,9, Oliver Eickelberg10 &  
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Prenatal exposure to tobacco smoke is a significant risk-factor for airway disease development. 
Furthermore, the high prevalence of pregnant smoking women requires the establishment of strategies 
for offspring lung protection. Therefore, we here aimed to understand the molecular mechanism of 
how prenatal smoke exposure affects fetal lung development. We used a mouse model recapitulating 
clinical findings of prenatally exposed children, where pregnant mice were exposed to smoke until 
c-section or spontaneous delivery, and offspring weight development and lung function was monitored. 
Additionally, we investigated pulmonary transcriptome changes in fetal lungs (GD18.5) by mRNA/
miRNA arrays, network analyses and qPCR. The results demonstrated that prenatally exposed mice 
showed intrauterine and postnatal growth retardation, and impaired lung function. 1340 genes and 
133 miRNAs were found to be significantly dysregulated by in utero smoke exposure, and we identified 
Insulin-like growth factor 1 (Igf1) as a top hierarchical node in a network analysis. Moreover, Igf1 mRNA 
was increased in female murine offspring and in prenatally exposed children. These findings suggest 
that prenatal smoking is associated with a dysregulation of several genes, including Igf1 in a sex-
specific manner. Thus, our results could represent a novel link between smoke exposure, abberant lung 
development and impaired lung function.
Smoking during pregnancy is a recognized risk factor for low birth weight1,2 and impaired lung function in off-
spring3–5. In addition, even a sole exposure to maternal nicotine, a component of tobacco smoke, affects the 
metabolism and the structuaral development of the offspring lung6. Furthermore, there is evidence for increased 
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risk of preschool wheeze7–9, asthma8,9 and COPD10–12 in the offspring. Despite this knowledge and intensive 
anti-tobacco campaigns in several countries, the number of women smoking during pregnancy remains high 
worldwide. These facts prompted demands for research on consequences of prenatal smoke exposure including 
downstream biological effects13.
Besides adverse health consequences of maternal smoking, it has been proposed that grandmaternal as well 
as grandpaternal smoking during pregnancy is sufficient to affect weight gain of the grandchildren, even if their 
mother was not smoking during her pregnancy14,15. Moreover, it was shown that grandmaternal smoking affects 
asthma susceptibility16–18 in grandchildren. These observations were supported by studies in rats where maternal 
perinatal s.c. nicotine induced airway hyperreactivity until the 3rd generation19. If these transgenerational effects 
hold true, even highly successful smoking cessation programs would take decades to become fully effective.
Various growth factors play a role during the process of fetal lung development20–26. As previous studies 
revealed, one of these factors is insulin-like growth factor (IGF), while it was shown that mice depleted from 
either Igf1 or its receptor Igf1r demonstrated a failure in lung development27,28. In addition to this, few studies 
showed sex-specific differences in the IGF-system of the offspring following maternal smoking29,30. Therefore, it is 
important to develop means to protect the developing fetal lung as well as to understand the mechanisms of how 
cigarette smoke affects fetal and early postnatal lung development.
Thus, in this study we aimed to investigate the underlying molecular mechanisms of in utero smoke exposure 
and the resulting predisposition for chronic lung diseases. Along this line, we identified dysregulations of 1340 
genes and 133 microRNAs in the fetal lung, while one central hierarchical node was Igf1. In addition, an increase 
of IGF1 was also observed in school children with prenatal and early-life cigarette smoke-exposure history.
Materials and Methods
For a detailed description of RNA isolation and qPCR please refer to the Supplementary Information.
Animal protocols. The study was conducted according to the guidelines for the use and care of laboratory 
animals according to the Federal Act on the Protection of Animals (Germany). The study was approved by the 
Government of the District of Upper Bavaria (GZ. 55.2-1-54-2532-91-11). Balb/c mice, obtained from Charles 
River (Sulzfeld, Germany), were housed in a specific pathogen-free facility with a 12 h day-night cycle at a constant 
temperature and humidity. The mice were provided with standard rodent chow and water ad libitum. Eight-week 
old virgin females were mated 1:1 with proven male breeder for 24 h (defined as embryonic day (ED) 0.5). 
To allow proper implantation of the fertilized oocyte, mice were exposed to smoke or filtered air (see below) only 
from gestational day (GD) 2.5 until spontaneous delivery or until GD 17.5 followed by caesarean section at GD 
18.5. Since the successful fertilization wasn’t possible at the start of exposure, non-pregnant mice were equally 
exposed to cigarette smoke (CS) until pregnancy could be excluded through maternal weight control. For cae-
sarean section (c-section), pregnant mice were anaesthetized with Ketamine/Xylazine on GD 18.5. Uteri were 
visually inspected for resorbed fetuses and the uterine position of each fetus was recorded. Fetuses were weighed 
and sacrificed by i.p. injection of pentobarbital for organ removal. Fetal lungs were carefully removed, weighed 
(Mettler Toledo, Greifensee, Switzerland), and stored in RNAlater (Ambion, Austin, USA) at 4 °C overnight and 
then at −80 °C until RNA isolation.
Cigarette smoke exposure protocol. Mainstream CS served as a surrogate for active smoking and was 
generated as previously described31. Briefly, smoke was generated from 3R4F Research Cigarettes (Tobacco 
Research Institute, University of Kentucky, Lexington, KY) and drawn into the exposure chamber with a mem-
brane pump. Mice were exposed to 10 cigarettes for 50 min every morning until c-section or spontaneous deliv-
ery. Total particulate matter (TPM) concentrations were monitored by drawing an air sample from the exposure 
chamber through a quartz fiber filter (at 3rd, 6th, and 9th cigarette, each day during the exposure). The TPM mass 
concentration was obtained by gravimetric analysis of the filters before and after exposure and was then related 
to the chamber volume.
Characterization of pregnant mice. After mating, maternal weight was monitored daily until delivery. 
Urine was collected four hours after the last smoke exposure and cotinine was quantified by ELISA (Calbiotech, 
Spring Valley, US). For an independent confirmation of smoke exposure, carbon monoxide hemoglobin (CO-Hb) 
was determined in venous blood obtained from the retrobulbar venous plexus in anesthetized animals 30 min 
after the last cigarette (Hemoxymeter (OSM3, Radiometer, Copenhagen).
Characterization of murine offspring. Body weight was recorded daily in spontaneously delivered off-
spring until postnatal day (PND) 56. Lung function was performed at PND21. A total of 303 offspring were ana-
lyzed (Supplementary Table S1). Since body weight was confounded by litter size, only pups from litters above the 
median (>6) were included in the final molecular analyses. To further avoid ill-defined seasonal effects, animals 
obtained from different experimental batches at different seasons were included in the molecular analyses.
Lung function analyses. Following intraperitoneal anesthesia (ketamine 140 mg/kg; xylazine 7 mg/kg), 
mice were tracheostomized, intubated (19 G tube) and placed on a warming plate. Pancuronium (1 mg/kg, i.p.) 
was added to avoid spontaneous breathing during examination. For baseline lung function measurements, 
mice were ventilated with a tidal volume of 11 ml/kg at a frequency of 150 breaths/minute with a positive 
end-expiratory pressure of 2 cm H2O on a computer controlled ventilator (FlexiVent®, SCIREQ©, Montreal, 
QC, Canada). The following perturbations were performed: Maximal Vital Capacity (MVC) maneuver, single 
compartment (snapshot), constant phase model (Primewave-8), and pressure-volume loops with constantly 
increasing pressure (PVr-P). All perturbations were performed one-by-one until three acceptable measurements 
(coefficient of determination > 0.95) were recorded in each individual subject, of which an average was calculated. 
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Due to a body weight difference in male and female mice, the inspiratory capacity was calculated in relation to 
the body weight. After lung function testing at baseline level, mice were transferred to a Buxco R/C system (Troy, 
NY) to assess airway reactivity. Metacholine (MCh) was applied to the intubated mice via an in-line nebulizer and 
administered at increasing concentrations (0, 12.5, 25, 37.5 mg/ml) for 20 sec. Resistance (R) and Compliance (C) 
were measured continuously for 3 min. The average was calculated and plotted against the MCh concentration.
Pediatric cohort. Peripheral blood mononuclear cells (PBMCs) were isolated from a subsample of 23 healthy 
children (age 4–15 years) with a history of early-life smoke exposure and compared to age-matched controls 
participating in the Munich Clinical Asthma Research Association (CLARA) study32. Early-life smoke exposure 
was defined as smoking of the mother during pregnancy and smoking of one or two parents at home at the time 
of inclusion into the study. ‘Non-smoking’ was defined as no smoking of either parent as well as no smoking 
at home throughout the pregnancy. According to this definition, six children were exposed (during pregnancy 
and currently at home), and 17 children had non-smoking parents. PBMC, isolated within 24 hours after blood 
withdrawal, were cultured (X-Vivo (Lonza, Basel, Switzerland) with plate-bound anti-CD3 (3 mg/mL) and sol-
uble anti-CD28 (1 mg/mL) at 37 °C for 48 h. RNA was isolated with the RNeasy Mini-Kit and processed (1 mg) 
with reverse transcriptase (Qiagen, Hilden, Germany). Gene-specific PCR products of IGF1 and IGFBP3 were 
amplified with the CFX96 Touch Real-time-PCR Detection System (Bio-Rad, Munich, Germany) for 40 cycles.
Ethics statement. The study has been approved by the local ethics committee of LMU Munich (project 
nr 379-08). All methods were carried out in accordance with relevant guidelines and regulations. Parents have 
agreed to participation in the study, and informed consent was obtained from all families.
Gene expression analysis in murine lungs at embryonic day 18.5. Selection criteria of samples for 
RNA profiling. Both androgens and estrogens can influence lung development and physiology in prenatal life33. 
To limit undefined effects from interactions between neighboring siblings of different sexes, we selected fetuses 
which had two neighbors of identical sex or were positioned at the end of the uterus having a neighbor of the 
same sex (Supplementary Fig. S1). We further took one male and one female offspring per litter. In order to avoid 
detecting acute but transient effects, the mRNA and miRNA profiling were performed 24 h after the last cigarette 
smoke exposure (ED 18.5).
Expression profiling. Total RNA (n = 12/group; each six males and females) was isolated using the miRNeasy 
Mini (QIAGEN) kit. The Agilent 2100 Bioanalyzer was used to assess RNA quality where only high quality RNA, 
(RIN ≥ 8.7, 260/280 ratio > 1.8, no degradation as detected by RNA agarose gel), was used for microarray analy-
sis. For mRNA profiling, 30 ng of total RNA was amplified using the Ovation PicoSL WTA System V2 in combi-
nation with the Encore Biotin Module (Nugen). Amplified cDNA was hybridized on an Affymetrix Mouse Gene 
ST 2.1 array plate. Staining and scanning were done according to the Affymetrix expression protocol including 
minor modifications as suggested in the Encore Biotin protocol. For microRNA profiling, 800 ng of total RNA was 
labeled with the FlashTag Biotin HSR kit (Genisphere) and hybridized on Affymetrix miRNA 3.0 arrays. Staining 
and scanning were done according to the Affymetrix expression protocol (Fluidics FS450_0002). Array data has 
been submitted to the GEO database at NCBI (GSE67888).
Data analysis. Statistical transcriptome analysis for mRNA and microRNA profiling from mice. The expres-
sion console (v.1.3.0.187, Affymetrix) was used for quality control and to obtain annotated normalized RMA 
gene-level data and DABG (standard settings including median polish and sketch-quantile normalization). Three 
samples from the filtered-air group (one male, two females) haven’t fulfilled the quality criteria and were there-
fore excluded from further analysis. Redundant probe sets with identical expression values in all samples were 
removed from the dataset. Statistical analyses were performed using the statistical programming environment34 
implemented in CARMAweb35. Gene wise testing for differential expression was done employing the (limma) 
t-test and Benjamini-Hochberg multiple testing correction (FDR < 10%). Sets of significantly regulated miRNAs 
were filtered for present calls in at least 60% of the samples in at least one group.
Upstream regulator and functional network analysis. The upstream regulator, network and functional analyses 
were generated through the use of IPA® (Ingenuity Pathway Analysis (QIAGEN)). First, the core analysis mod-
ule of IPA® was applied to a set of 1340 CS-regulated (|FC| > 1.2, unadj. p < 0.05) mRNAs using default settings 
including direct and indirect relationships as well as endogenous metabolites. The Mouse Gene 2.1 ST Array was 
chosen as reference set. Molecules identified as upstream regulators of the dataset were filtered to those transcrip-
tion regulators, which were regulated in the initial dataset. These molecules were displayed as a network together 
with their downstream targets. The “grow” function of IPA® was applied to the transcription regulators to identify 
CS-regulated microRNAs targeting these transcription regulators. Targeting microRNAs with non-inverse regu-
lation were filtered out. An additional core analysis of the molecules in the upstream regulator network was used 
to identify the functional role of the top networks of these molecules.
Statistical analyses. The weight gain of mothers and offspring was analyzed using SAS PROCs GLM and 
MIXED for repeated measure analyses (SAS Institute Inc. 2011. SAS® 9.3 System Options: Reference, Second 
Edition. Cary, NC: SAS Institute Inc.). Analyzing the weight gain of animals over time requires consideration 
in between-group effects as well as within subject effects. Typically, control and exposed groups started off with 
approximately equal weights but ended up being different in their average weight by the end of the study period. 
In general, the trend parameters, i.e. the shapes of the weight gain curves, differ between groups. This is accounted 
for by appropriately tested and chosen study group specific trend parameter interactions with time, e.g. by for-
ward or backward selection. Weight gain and group* time interaction parameters were quantified by the natural 
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measure milligram per day (mg/d) with 95%-confidence intervals (CI) and p-values. The corresponding synoptic 
graphical display of growth curves for control and exposure groups was obtained employing SAS PROC GPLOT. 
The remaining molecular data obtained in mice were tested for normal distribution using D’Agostino and Pearson 
omnibus normality test (GraphPAD Prism, GraphPad Software Inc. 2007). Mann-Whitney U test or t-test was 
applied where appropriate. Differences in mRNA expression levels of children with smoking and non-smoking 
parents were tested on log ∆CT scale using tobit regression analysis36.
Data availability statement. The microarray data has been submitted to the GEO database at NCBI 
(GSE67888) and will be available for all readers upon publication.
Results
Effects of CS exposure on maternal characteristics of successful pregnancy. Exposure to CS was 
monitored by assessing levels of urinary cotinine and peripheral blood CO-Hb, which were both significantly 
increased in CS-exposed female mice (Table 1). The average TPM exposure was 321 + 89 mg/m³. Eight-week old 
animals, as used in this study, still gain weight with the age. Age-related weight gain was clearly compromised in 
CS-exposed non-pregnant mice (mean −80 mg/d; CI 75–84 mg/d; p < 0.0001 Supplementary Fig. S2). This was 
also true for pregnant mice: CS-exposed dams lagged behind in weight gain by −157 mg/d (95%-CI: 145–168), 
p < 0.0001 (Fig. 1). This difference remained significant even after the maternal weight was corrected for the size 
of the litter. Despite the effect of CS on maternal weight gain, the pregnancy rate, duration and number of viable 
pups or visibly resorbed fetuses did not differ significantly between the groups. Similarly, the number of female 
AIR CS p-value
Urine cotinine [mg/ml]#*
(n)
117 ± 26
7
600 ± 25
15 <0.0001
Co-Hb [%] #*
(n)
1.3 ± 0.2
17
6.3 ± 0.6
22 <0.0001
Pregnancy rate [%]
(n)
13.1 ± 8.8
32
9.6 ± 6.9
29 0.3
Pregnancy duration [d]
(n)
19.8 ± 0.5
12
19.8 ± 0.6
12 >0.99
Litter size
(n)
6.2 ± 1.8
32
5.7 ± 1.9
29 >0.99
Visible resorptions
(n)
0.5 ± 0.6
20
1.0 ± 0.5
17 0.1
Male offspring [%]
(n)
43.2 ± 10.2
77
51.3 ± 23.0
72 0.3
Maternal weight at section [g]
(n)
34.4 ± 2.1
15
32.8 ± 2.4
8 0.1
Table 1. Characteristics of maternal exposure and reproduction. #Mean ± SD, *analyzed in non-pregnant 
animals; Pregnancy rate: percentage of female mice with successfully established pregnancy after overnight 1:1 
mating.
Figure 1. Weight trends of pregnant mice exposed either to CS or AIR. Dams were exposed daily to mainstream 
CS (grey) or AIR (blue) from ED 2.5 until delivery. Graphs depicts all observed values, especially the min and 
max values for each time point (open circles), and the corresponding optimum polynomial model fits (lines); 
p < 0.0001 after considering weight gain and group* time interactions and litter size. The interaction of litter size 
with smoke exposure was not significant and was therefore not included in the model.
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and male offspring were equal in both groups indicating that the parameters of successful pregnancy per se were 
not affected by the CS protocol applied (Table 1).
Reduced intrauterine and postnatal growth of exposed offspring. Smoke-exposed fetuses 
(ED18.5) had significantly lower body and lung weights as compared to the air-exposed animals. Pulmonary 
hypotrophy, as indicated by lower lung/body weight ratio, was more pronounced in female offspring resulting in 
lower lung/body weight ratios in females but not in males (Fig. 2A–C). As expected, postnatal weight gain was 
lower in females independent of prenatal CS-exposure. Furthermore, the offspring from litters with less than six 
animals had a stronger weight gain as compared to animals from larger litters (>6) possibly due to the different 
breast milk availability per animal. Prenatal CS-exposure retarded weight gain in offspring as investigated until 
PND 56 (Fig. 3A,B). When we corrected our analyses for sex and litter size, the reduced postnatal weight gain of 
prenatally CS-exposed animals remained highly significant (mean −6.7 mg/d, 95%-CI [4.0, 9.4]).
Reduced lung function in offspring. Next, we investigated whether smoke-induced intrauterine and postnatal 
growth retardation was associated with lung function deficits. We found that the inspiratory capacity was signifi-
cantly reduced in three-week old animals after intrauterine CS-exposure. When we stratified for sex, this decrease 
Figure 2. Intrauterine growth retardation after CS exposure. Weight at cesarean section (E18.5) (A) body 
weight (B), lung weight and (C), lung-to-body weight ratios of fetuses. AIR (blue) or CS-exposed (orange) male 
(•) and females (▲) fetuses. Litter size > 6, mean ± SD; unpaired t test (*p < 0.05, **p < 0.01, ***p < 0.001, 
****p < 0.0001).
Figure 3. Intrauterine smoke exposure reduces postnatal growth weight gain. Postnatal weight gain of female 
(upper panel) and male (lower panel) offspring until PND 56 after in utero CS (grey) or AIR (blue) exposure. 
Graphs depicts all observed values, especially the min and max values for each time point (open circles), and 
the corresponding optimum polynomial model fits (lines); p < 0.0001 after considering weight gain and group* 
time interactions.
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was present in both males and females (Fig. 4A). In contrast, airway hyperreactivity was only seen in female off-
spring, even in the absence of any experimental allergen challenge (Fig. 4B,C).
Gene expression networks in fetal lungs. With the establishment of our model that mimics findings of prenatally 
smoke exposed children, we next aimed to shed more light on the molecular mechanisms preceding impaired lung 
function of CS-exposed offspring. Therefore, we performed mRNA and microRNA arrays in fetal lungs, which 
revealed 1340 differentially regulated mRNAs (|FC| > 1.2, unadj. p-value < 0.05) and 133 microRNAs (unadj. 
p-value < 0.05) (Supplementary Fig. S3). The array data is also available at the GEO database at NCBI (GSE67888).
To identify top biological functions associated with changes in global mRNA expression patterns, the 
core analysis module of the Ingenuity® software was used. Besides other functions (Supplementary Table S2), 
those associated with embryonic and organismal development were strongly affected by in utero smoking 
(Supplementary Table S3). To investigate which key developmental molecules could be responsible for these 
changes, we identified upstream regulators within the dataset and filtered those to transcription regulators which 
showed mRNA dysregulation. These molecules were displayed as a network together with their downstream 
targets (Fig. 5). Three transcription factors involved in transcriptional repression such as E2F transcription fac-
tors 7 and 8 (E2f7, E2f837), Myb-related protein B (Mybl2)38 responsible for control of cellular proliferation and 
senescence and histone-lysine N-methyltransferase (Suv39h2) which is highly specific for H3K9 trimethylation39, 
were up-regulated. In contrast, two transcription factors related to lipid metabolism (CCAAT/enhancer bind-
ing protein (C/EBP) alpha (Cebpa) and Sterol regulatory element binding transcription factor 1 (Srebf1)) were 
down-regulated. In a next step, we included counter-regulated miRNAs targeting the transcription factors to the 
network, as miRNAs are an additional important level of regulation. Most down-regulated functions involved 
lipid metabolism and survival, whereas the top up-regulated functions were related to inflammatory and respira-
tory diseases (Supplementary Table S4). To gain insight into the interactions of these molecules, we performed 
a network analysis and found Insulin-like growth factor 1 (Igf1) as top hierarchical node in the subnetwork 
associated with embryonic and organ development (Fig. 6). The in silico analysis of this Igf1-driven subnetwork 
revealed organismal survival, organismal injury and abnormalities and, most importantly, respiratory disease as 
its major function (Table 2).
Pulmonary Igf1 and Igf-binding protein (Igfbp3) expressions in mice and exposed children. Since 
the in silico analyses suggested Igf1 as a main driver of reduced lung weight and function, we further focused on 
this growth hormone. Igf1 is almost completely bound to one of the six binding proteins (Igfbp). Igfbp3 is the 
most abundant protein that accounts for the majority of all IGF binding. As it is also downregulated in our array 
(Fig. 5) we additionally included this hormone in the analysis. Igf1 mRNA expression was significantly increased 
in female prenatally smoke-exposed lungs at day E18.5, whereas Igfbp3 expression was decreased. This effect was 
no longer found in offspring of three weeks of age (Fig. 7). To determine whether our model more or less reflects 
the human situation, we investigated anti-CD3/CD28-stimulated PBMCs of healthy school-aged children with 
Figure 4. In utero CS exposure affects lung function in adolescent offspring. (A) Inspiratory Capacity (IC)/body 
weight; (B,C), Airway hyperreactivity (AHR); Male (•) and female (▲) offspring; measured at d21 after birth; 
AIR- (blue), CS-exposure (orange). mean ± SD, MWU; (*p < 0.05; **p < 0.01 ***; p < 0.001).
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early-life smoke exposure. Interestingly, mRNA expression of IGF1 was significantly higher in PBMCs from chil-
dren with smoking parents as compared to children from non-smoking parents, whereas mRNA expression of 
IGFBP3 was not affected (Fig. 8, p = 0.008; p = 0.16).
Discussion
In this study, we aimed to investigate underlying molecular mechanisms for lung development deficits due to 
in utero cigarette smoke exposure by using an animal model of maternal smoking during pregnancy. Prenatally 
exposed mice showed intrauterine and postnatal growth retardation and several alterations on the pulmonary 
transcriptomic and miRNA levels at E18.5. In addition to this, a reduction of lung function in adolescence was 
detected, which is of interest as it is a recognized smoking-induced pathology in children3,4,40–43. Extensive 
mRNA/miRNA profiling of fetal lungs revealed a dysregulation of 1340 mRNAs and 133 miRNAs of CS-exposed 
offspring compared to controls. A subsequent in silico construction of networks of transcriptional regulators, 
revealed, beyond others, Igf1 as major hub in fetal smoke exposed lungs. Deregulation of pulmonary Igf1 together 
with its main binding partner Igfbp3 was also confirmed by qRT-PCR in murine offspring and further corrobo-
rated in school-aged children by showing reduced IGF1 expression in PBMC after prenatal and early-life smoke 
exposure.
As our goal was to investigate the consequences that are purely related to prenatal smoke-exposure and not to 
a compromised pregnancy by maternal stress, we designed the exposure in a way that the basic parameters of suc-
cessful pregnancy remained unaltered. As smoking is linked to reduced fertility and increased rates of abortion44, 
mice were subjected to smoke after fertilization but prior to the formation of the lung bud. In order to compare 
the severity of our smoke exposure to other studies and human data, we assessed cotinine, a nicotine metabolite 
in urine, and carboxyhemoglobin (Co-Hb) levels in the blood.
We observed an 5.12-fold increase of urine cotinine levels, and a 4.84-fold increase in Co-Hb in our model 
in smoke exposed mothers compared to air controls. However, it has to be noted that in this study samples were 
drawn 4 h after the last smoke exposure, and the half-time of cotinine in C57BL/6 mice is only 38 min45. Thus, 
we assume the fold-increase in urine cotinine levels are reflecting light smoking when compared to data from a 
large cohort of pregnant women46. Nonetheless, intrauterine growth retardation was pronounced and – more 
importantly - sustained into adulthood, while smoking was stopped at birth. Surprisingly, the offspring did not 
show catch-up weight gain after weaning, even after the adjustment for sex, litter size and consideration of sea-
sonal effect; thus it is intriguing to speculate that intrauterine smoke-exposure causes a persistent developmental 
disadvantage.
We observed lung function deficits in CS-exposed offspring at the age of three weeks. Of note, female offspring 
exhibited spontaneous airway hyperreactivity (AHR), even in the absence of allergen challenge, and showed a 
significant higher expression of Igf1 at E18.5, thus indicating a possible link between Igf1 and lung function. It 
is intriguing to speculate that the observed lung function differences are due to increased airway remodeling, 
which has been previously reported in similar models of prenatal smoke exposure47, which we however could not 
investigate in this study.
Figure 5. Network of top deregulated transcriptional regulatory factors in fetal smoke exposed lungs (E18.5). 
The core analysis module of the Ingenuity® software was used to identify top biological functions of 1340 
mRNAs (Affymetrix Mouse Gene ST 2.1 array) deregulated by CS in fetal lungs (female and male merged). This 
dataset was filtered to transcriptional regulators showing deregulation and are displayed as a network together 
with their downstream targets.
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Sexual dimorphism is well known in physiological and non-physiological lung responses48 including develop-
mental, hormonal, airway structural and functional differences. For example, female fetuses start mouth move-
ments49, surfactant synthesis and maturation earlier than male fetuses50. In early childhood, girls have larger 
airways in relation to lung size, and lower specific airway resistance than boys (reviewed in51). Thus, it is con-
ceivable that environmental insults act differently on females and males during development. Nonetheless, the 
assessment of sex differences has so far been neglected in most inter- or trans- generational animal models.
Fetal smoke-exposed lungs showed regulation of signaling molecules at multiple levels from transcription 
regulators to their down-stream targets. To avoid seeing acute and transient effects, arrays were performed one 
day after the last smoke exposure on pups delivered by c-section (E18.5). Thus, even though the fold–changes of 
gene expression were low, they might indicate the onset of pathology and hence be more relevant than stronger 
events occurring at the end of molecular cascades.
Lung development is a precisely controlled process of parallel proliferation, differentiation and apoptosis. 
Transcriptional regulator network showed dysregulation of the genes that are relevant for development and the 
onset of respiratory diseases. The transcription factors E2f7 and E2f8 protect cooperatively against excessive apop-
tosis via repression of E2f1 and are strictly required for embryonic development37,52. Mybl2, which controls cell 
cycle progression and cell fate in embryonic stem cells2, was equally upregulated implying disturbed early devel-
opmental processes. On the other hand, Cebpa and Srbf1 which are considered to be critical for lung maturation 
and respiratory epithelial differentiation (Cebpa), were decreased53–55.
IGF1 is an important regulator of somatic growth and cell differentiation56 where the absence of its signaling 
results in severe growth failure57,58. A specific role of IGF1 for lung development is indicated by strong IGF1 
upregulation in lung structural cells in bronchopulmonary dysplasia59 or severe pulmonary hypoplasia resulting 
from diaphragmatic hernia60. Igf1 deficient mice were shown to exhibit growth failure which was more pro-
nounced in lungs as compared to body weight61,62.
Figure 6. Igf1 is the top hierarchical node of transcriptional regulators after intrauterine CS exposure Counter-
regulated microRNAs targeting the network of transcriptional regulators and their downstream targets were 
identified and included in this dataset. (E18.5, female and male merged). To identify the functional role of the 
top networks of these molecules, a second core analysis of the molecules of this enlarged dataset was applied. 
The results are visualized as network.
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So far, data relating prenatal smoke exposure to changes of pulmonary IGF-1 are limited. One study in adult male 
smokers reported reduced serum IGF-1 and IGFBP-3 levels that returned to normal levels after smoking cessation63. 
Two mouse studies have previously implicated the Igf1 axis with prenatal smoke exposure, and of note both found 
sex-specific effects as we did in this study. The first one used Balb/c mice that were nose-only exposed during the 
entire pregnancy, and was in contrast to our findings showing lower Igf1 mRNA expression in 30-day old female 
Categories Diseases or Functions Annotation p-Value # Molecules
Organismal Survival
organismal death 3.64E-05 15
survival of organism 3.90E-05 11
Organismal Injury & Abnormalities
lymphocytic cancer 1.11E-05 9
non-Hodgkin’s disease 6.94E-05 8
biliary tract tumor 6.71E-05 4
biliary tract cancer 6.71E-05 3
Respiratory Disease
obstructive pulmonary disease 7.95E-06 5
atelectasis 2.89E-05 3
small cell lung cancer 6.32E-05 3
abnormal composition of pulmonary 
surfactant 2.60E-06 2
congenital pulmonary alveolar proteinosis 3.66E-06 2
community acquired pneumonia 1.06E-05 2
abnormal secretion of pulmonary surfactant 4.90E-05 2
primary atelectasis 9.67E-05 2
Cell Death & Survival
apoptosis of myeloma cell lines 5.45E-05 5
survival of hepatic stellate cells 2.87E-05 2
DNA Replication. Recombination & Repair DNA damage 3.18E-05 5
Respiratory System Development & Function abnormal morphology of type II pneumocytes 1.11E-06 3
Inflammatory Response cytotoxic reaction of breast cancer cell lines 3.03E-05 2
Organ Development growth of mammary duct 6.59E-05 2
Table 2. Top 20 Diseases and Biofunctions associated with changes in IGF1 network mRNA expression 
patterns (diseases and functions significant to network molecules). Some diseases and functions appear in more 
than one category. Only one category for each function is shown for simplicity. *The p-value of overlap was 
calculated by the Fisher’s Exact Test.
Figure 7. Pulmonary gene expressions of Igf1 and Igfbp3 after intrauterine CS exposure. Igf1 (A,C) and Igfbp3 
(B,D) gene expression in lungs of E18.5 and PND21 males (•) and females (▲); AIR- (blue) and CS- (orange) 
exposure. Normalized relative quantity (NRQ) with TATA-binding protein (Tbp) as reference gene. Mean + SD, 
n ≥ 6; MWU (*p < 0.05).
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offspring in comparison to control29. This was related to sex-dependent differences in promoter methylation of Igf1r. 
This was recently confirmed in a second study using a prenatal smoke model in C57Bl/6 mice, which also showed 
that Igfr1 CpG methylation was organ- and sex-specific64. The difference to our study could be due to the different 
time point of analysis as the observed increase in Igf1 levels in our study was only found at E18.5, but not at PND 21 
and we did not investigate d30. Along this line, it has been found that Igf1 levels decrease postnatally65. Concerning 
the Igf1 levels in male offspring, our results were in accordance to the abovementioned study by Meyer et al. showing 
no significant change in Igf1 expression. However, other investigators did not reveal such a relationship66.
In humans, maternal smoking in pregnancy has been associated with lower placental GH and human cord blood 
IGF-1 protein concentrations67. Another study, as well, showed a lower cord blood IGF-1 in infants from mothers 
who smoked during early pregnancy, with the strongest decline in girls as compared to boys68. Similar to our find-
ings in mice, the growth hormone deregulation was more pronounced in females. In this study, we partly validated 
our findings from the mouse model by the observation that IGF-1 levels are increased in PBMCs from in utero 
CS-exposed, healthy children at school age. However, the number of human samples used in the present study did 
not allow stratifying for sex. Further, these children were healthy; thus we do not have any further information on 
whether they had subtle deficits in lung function and as lung development is vastly different between mice and 
humans69 they do not reflect the same developmental stages as in our murine model. Nonetheless, this is a first 
hint that IGF-1 dysregulation might be an important effector of in utero CS-exposure and might indicate a certain 
‘molecular defect’ in smoke-exposed children, which could for example result in a changed susceptibility to develop 
chronic lung diseases such as asthma in later life. Thus, this needs to be further investigated in future studies.
We acknowledge several potential limitations of our study. First, similar to human studies2, murine models do 
not allow to clearly separate the effects of intrauterine growth retardation from smoke exposure on the developing 
lung. Second, despite the apparently normal course of pregnancy, placental functions could be affected. Prenatal 
smoking, albeit at higher doses, has been shown to influence decidua immune responses in mice and humans70. 
Nicotine exposure has further been linked to altered placental development and function in rats71. In humans, 
maternal smoking has been related to global72 and gene-specific73 placental DNA-methylation thus indicating an 
abnormal placental function. Third, although air and smoke test animals were handled in the same way, smoking, is 
an additional – although unavoidable -, stress factor itself. Moreover, maternal stress during pregnancy can induce 
low-level maternal corticosterone74 and increase responsiveness to allergen challenge in offspring74,75. Thus, it is 
possible that besides smoking, elevated maternal stress hormones might have contributed to our findings.
In summary, we here show that prenatal smoke exposure is associated with deregulated pulmonary transcrip-
tomes, miRNA levels and Igf1 in a sex-specific manner. To our knowledge we are the first to report a change in 
pulmonary transcriptomes and miRNA levels at day E18.5, which Ingenuity Pathway Analysis (IPA) predicted 
to be involved in respiratory disease as one of the top hits. These findings, taken together with the previously 
reported Igf1 dysregulation might not only indicate an aberrant lung development, but might also alter the off-
springs’ response to environmental insults, such as allergens or cigarette smoke and therewith predispose for the 
development of chronic lung diseases.
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